<DOC>
	<DOCNO>NCT01004796</DOCNO>
	<brief_summary>RATIONALE : Studying sample tumor tissue patient cancer laboratory may help doctor learn change occur DNA identify biomarkers related cancer . PURPOSE : This research study look tissue sample patient breast cancer .</brief_summary>
	<brief_title>Study Biomarkers Tissue Samples From Patients With Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Identify mass spectroscopy site-specific mutagenesis post-translational modification estrogen-related receptor alpha ( ERRα1 ) responsible ERRα1 function constitutive activator rather down-modulator transcription estrogen response element-regulated gene tumor patient breast cancer . - Produce panel monoclonal antibody ERRα1 standard hybridoma method use distinguish activator repressor form receptor patient . - Validate utility immunohistochemistry ( IHC ) assay ERRα-specific serum perform IHC quantitative real-time PCR primary breast carcinoma . - Correlate result IHC study archival paraffin section primary breast tumor use monoclonal antibody ERRα1 , ERRα1 status , currently assay biomarkers , course treatment patient outcomes . OUTLINE : Breast tumor tissue sample obtain tissue bank form frozen tumor paraffin-embedded section microarray block . Monoclonal antibody ( MOABs ) ERRα1 produce use antigen tissue sample immunohistochemical study perform use MOABs . Cytogenetic study perform DNA purify tissue sample .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis breast cancer Tumor tissue available The following clinical information must know : ErbB2 status Nodal status Percent S phase Hormone receptor status : Estrogen receptor progesterone receptor status know PATIENT CHARACTERISTICS : Menopausal status specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>breast cancer</keyword>
</DOC>